Detalles de la búsqueda
1.
A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choices.
Support Care Cancer
; 30(10): 7913-7922, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35732748
2.
A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis.
Support Care Cancer
; 30(7): 6135-6144, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35426046
3.
Prophylactic pegfilgrastim to prevent febrile neutropenia among patients receiving biweekly (Q2W) chemotherapy regimens: a systematic review of efficacy, effectiveness and safety.
BMC Cancer
; 21(1): 621, 2021 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34044798
4.
Trends in use of primary prophylactic colony stimulating factors and neutropenia-related hospitalization in commercially insured patients receiving myelosuppressive chemotherapy in the United States: 2005-2017.
J Oncol Pharm Pract
; 27(1): 128-142, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32326872
5.
Trends in the use of primary prophylactic colony-stimulating factors and neutropenia-related hospitalization in elderly cancer patients receiving myelosuppressive chemotherapy in the USA: 1995-2015.
Support Care Cancer
; 28(6): 2637-2649, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31624920
6.
Patterns of granulocyte colony-stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy.
Support Care Cancer
; 28(9): 4413-4424, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31919669
7.
A Survey of Oncologists' Perceptions and Opinions Regarding the Use of Granulocyte Colony-Stimulating Factors.
J Cancer Educ
; 35(1): 178-186, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31656028
8.
Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes.
Pharmacoepidemiol Drug Saf
; 26(11): 1357-1366, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28809079
9.
Lifestyle, distress, and pregnancy outcomes in the Childhood Cancer Survivor Study cohort.
Am J Obstet Gynecol
; 212(1): 47.e1-10, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25068563
10.
A systematic review of dental late effects in survivors of childhood cancer.
Pediatr Blood Cancer
; 61(3): 407-16, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24424790
11.
Variations in hospitalization and emergency department/observation stays using the oncology care model methodology in Medicare data.
Curr Med Res Opin
; 36(9): 1519-1527, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32715807
12.
Duration of short-acting granulocyte colony-stimulating factor for primary prophylaxis and risk of neutropenia-related hospitalization in older patients with cancer.
J Geriatr Oncol
; 11(8): 1309-1315, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32624415
13.
Impairments that influence physical function among survivors of childhood cancer.
Children (Basel)
; 2(1): 1-36, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25692094
14.
A systematic review of selected musculoskeletal late effects in survivors of childhood cancer.
Curr Pediatr Rev
; 10(4): 249-62, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25403639
15.
Second stage of labor and intraventricular hemorrhage in early preterm infants in the vertex presentation.
J Matern Fetal Neonatal Med
; 26(13): 1292-8, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23484821
16.
Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia.
J Cancer Surviv
; 6(4): 388-97, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22956305
Resultados
1 -
16
de 16
1
Próxima >
>>